Stock Research for AKZOY

AKZOY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AKZOY Stock Chart & Research Data

The AKZOY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AKZOY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AKZOY Due diligence Resources & Stock Charts

The AKZOY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AKZOY Detailed Price Forecast - CNN Money CNN View AKZOY Detailed Summary - Google Finance
Yahoo View AKZOY Detailed Summary - Yahoo! Finance Zacks View AKZOY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AKZOY Trends & Analysis - Trade-Ideas Barrons View AKZOY Major Holders - Barrons
NASDAQ View AKZOY Call Transcripts - NASDAQ Seeking View AKZOY Breaking News & Analysis - Seeking Alpha
Spotlight View AKZOY Annual Report - CompanySpotlight.com OTC Report View AKZOY OTC Short Report - OTCShortReport.com
TradeKing View AKZOY Fundamentals - TradeKing Charts View AKZOY SEC Filings - Bar Chart
WSJ View Historical Prices for AKZOY - The WSJ Morningstar View Performance/Total Return for AKZOY - Morningstar
MarketWatch View the Analyst Estimates for AKZOY - MarketWatch CNBC View the Earnings History for AKZOY - CNBC
StockMarketWatch View the AKZOY Earnings - StockMarketWatch MacroAxis View AKZOY Buy or Sell Recommendations - MacroAxis
Bullish View the AKZOY Bullish Patterns - American Bulls Short Pains View AKZOY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AKZOY Stock Mentions - StockTwits PennyStocks View AKZOY Stock Mentions - PennyStockTweets
Twitter View AKZOY Stock Mentions - Twitter Invest Hub View AKZOY Investment Forum News - Investor Hub
Yahoo View AKZOY Stock Mentions - Yahoo! Message Board Seeking Alpha View AKZOY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AKZOY - SECform4.com Insider Cow View Insider Transactions for AKZOY - Insider Cow
CNBC View AKZOY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AKZOY - OTC Markets
Yahoo View Insider Transactions for AKZOY - Yahoo! Finance NASDAQ View Institutional Holdings for AKZOY - NASDAQ


Stock Charts

FinViz View AKZOY Stock Insight & Charts - FinViz.com StockCharts View AKZOY Investment Charts - StockCharts.com
BarChart View AKZOY Stock Overview & Charts - BarChart Trading View View AKZOY User Generated Charts - Trading View




Latest Financial News for AKZOY


Akzo Nobel loans break for trading
Posted on Thursday September 20, 2018

The US$6.44bn in term loans backing Carlyle Group and Singaporean wealth fund GIC’s acquisition of Akzo Nobel’s chemicals business allocated and broke for trading on Thursday. The US$4.34bn seven-year term loan B broke at 100.375-100.75 on Thursday, while the US$2.1bn-equivalent euro-denominated facility broke at 100.5-101. Pricing on the US$4.34bn term loan B was finalized at 325bp plus Libor, tightened from earlier guidance of 350bp-375bp range and 400bp-425bp range at launch.


Envision’s $5.05 billion loan marks jumbo buyout trio
Posted on Thursday September 20, 2018

The $5.05 billion (3.81 billion pounds) term loan for Envision Healthcare is the third massive leveraged loan to hit the market since September and also looks set to benefit from huge institutional demand which has already seen multibillion buyout loans for Thomson Reuters’ F&R business, Refinitiv, and Akzo Nobel’s Specialty Chemicals business successfully placed. Envision’s loan will bring the total of jumbo loans syndicated since early September to US$20.7bn, in addition to the US$9.25bn loan for Refinitiv and Akzo Nobel’s US$6.44bn loan. Although the commitment deadline for Envision’s loan is October 1, the deal is already fully subscribed and is expected to tighten in line with the two previous jumbo deals, bankers said.


AkzoNobel leading in decorative paints and woodcare in Spain with the acquisition of Xylazel S.A.
Posted on Thursday September 20, 2018

AKZOY) has acquired Xylazel S.A. (Xylazel), a 100% subsidiary of Pharma Mar S.A. (PHM). With this acquisition AkzoNobel strengthens its business and becomes a leader in the decorative paints market in Spain. The transaction marks the 45-year anniversary of AkzoNobel on the Spanish market.


Biggest Buyout Financings Steamroll Over Investor Safeguards
Posted on Wednesday September 12, 2018

The year’s biggest buyout financing, backing the $20 billion acquisition of Thomson Reuters Corp.’s spinoff, Refinitiv, is challenging some hard-won investor protections. The deals are bucking a trend of investor pushback in Europe this year. In recent months power has shifted back in favor of high-yield investors, particularly in Europe, where at least 11 deals have either been delayed or withdrawn so far this year, and swathes of transactions that priced were heavily amended.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.